Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Biopsy of Sentinel Lymph Node Considered Safe and Effective in Head and Neck Melanomas

Sentinel lymph node (SLN) biopsy, a common procedure to determine whether melanoma has spread, can be utilized safely and effectively even with tumors in the head and neck area according to a new study from the University of Michigan Comprehensive Cancer Center.

SLN biopsy is routinely offered to patients with melanoma meeting or exceeding a certain size. However, many surgeons believed the intricate anatomy combined with the crucial nerves and blood vessels in the head and neck area created an unsafe and inaccurate setting for an SLN biopsy of that region.

In the current study, which appears online in Cancer, researchers reviewed the records of 353 patients with head and neck melanoma who, over a 10-year period, had undergone an SLN biopsy at the University of Michigan. Upon assessment, researchers found the SLN could be determined in all but 1 patient. Additionally, during the procedures, no patients incurred permanent nerve injuries.

Approximately 20% of the patients had at least 1 SLN positive for cancer. They were referred for complete removal of additional lymph nodes.

For the 283 patients with negative sentinel nodes, 12 recurred in the area where the SLN was located. This suggests that the test generated 12 false-negative results. In other words, a negative test was inaccurate 4% of the time. This is comparable to the rate seen when SLN biopsy is performed for melanomas in other areas of the body.

Furthermore, SLN biopsy was the greatest predictor of a patient’s cancer survival post surgery, including recurrence-free survival, according to the researchers.

Related Items
November 4, 2019 — Oncology News & Updates
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Web Exclusives published on October 28, 2019 in Head and Neck Cancer
Concurrent Chemotherapy with Reirradiation for Head and Neck Cancer
TOP - Daily published on June 17, 2011 in Head and Neck Cancer
Concurrent Chemotherapy with Reirradiation for Head and Neck Cancer
TON - Daily published on June 17, 2011 in Head and Neck Cancer
Infrastructure Issues in the US Drug Supply: Where Did the Drugs Go?
Timothy G. Tyler, PharmD, FCSHP
JHOP - March 2011, Vol 1, No 1 published on March 22, 2011 in Head and Neck Cancer
Last modified: September 8, 2015